Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation.

Hyperlipidemias and small dense LDLs in patients with high-triglyceride low-HDL syndromes lead to a prolonged half life of apoB-containing particles. This is associated with reactive oxygen species (ROS) activation and leads to formation of oxidized LDL (Ox-LDL). Generators of ROS in macrophages (MACs) include myeloperoxidase (MPO)-mediated respiratory burst and raft-associated NADPH-oxidase. The intracellular oxidant milieu is involved in cellular signaling pathways, like ion-transport systems, protein phosphorylation, and gene expression. Lipid oxidation through ROS can amplify foam cell formation through Ox-LDL uptake, leading to formation of ceramide (Cer)-rich lipid membrane microdomains, and is associated with expansion of the lysosomal compartment and an upregulation of ABCA1 and other genes of the AP3 secretory pathway. Ox-LDL may also affect cell-surface turnover of Cer-backbone sphingolipids and apoE-mediated uptake by LRP-family members. In contrast, HDL-mediated lipid efflux causes disruption of lipid membrane microdomains and prevents foam cell formation. Oxidation of HDL through MPO leads to a failure of lipid efflux and enhancement of MAC loading. Therefore, lipid rafts and oxidation processes are important in regulation of MAC foam cell formation and atherosclerosis, and the balance between oxidant and antioxidant intracellular systems is critically important for efficient MAC function.

[1]  V. Bamm,et al.  Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. , 2003, Biochemistry.

[2]  M. Fishbein,et al.  Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL , 2001, Circulation.

[3]  D. Lange,et al.  Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. , 1989, Journal of periodontal research.

[4]  E. Smart,et al.  Lipids: potential regulators of nitric oxide generation. , 2004, American journal of physiology. Endocrinology and metabolism.

[5]  M. Nakano,et al.  Formation of ceramide‐enriched domains in lipid particles enhances the binding of apolipoprotein E , 2005, FEBS letters.

[6]  W. Nacken,et al.  Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. , 2001, Biochemistry.

[7]  T. Michel,et al.  Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. , 1998, Biochemistry.

[8]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[9]  M. Krieger,et al.  Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.

[10]  M. Quon,et al.  High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases* , 2003, The Journal of Biological Chemistry.

[11]  T. Kelley,et al.  Macrophage-Colony-Stimulating Factor-Induced Activation of Extracellular-Regulated Kinase Involves Phosphatidylinositol 3-Kinase and Reactive Oxygen Species in Human Monocytes1 , 2002, The Journal of Immunology.

[12]  Pin-Lan Li,et al.  Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. , 2004, Kidney international.

[13]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[14]  J. Heinecke,et al.  Oxidized HDL: the paradox-idation of lipoproteins. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Eaton,et al.  Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Sawamura,et al.  Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-κB through an Increased Production of Intracellular Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.

[17]  S. Yokoyama,et al.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.

[18]  E. Vizi,et al.  Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.

[19]  B. Brüne,et al.  Oxidized low-density lipoprotein depletes PKCalpha and attenuates reactive oxygen species formation in monocytes/macrophages. , 2006, Cardiovascular research.

[20]  M. Nakano,et al.  Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages* , 2004, Journal of Biological Chemistry.

[21]  M. Nikolova-Karakashian,et al.  High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner* , 2002, The Journal of Biological Chemistry.

[22]  G. Assmann,et al.  HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. , 2004, The Journal of clinical investigation.

[23]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[24]  M. Raftery,et al.  Oxidation of High Density Lipoproteins , 1998, The Journal of Biological Chemistry.

[25]  Gerd Schmitz,et al.  ABCA1: regulation, trafficking and association with heteromeric proteins , 2002, Annals of medicine.

[26]  V. Pasceri,et al.  Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.

[27]  T. Ganz Hepcidin--a peptide hormone at the interface of innate immunity and iron metabolism. , 2006, Current topics in microbiology and immunology.

[28]  M. Kinter,et al.  Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells* , 2006, Journal of Biological Chemistry.

[29]  Barry Halliwell,et al.  Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.

[30]  M. Aviram,et al.  Flavonoids protect LDL from oxidation and attenuate atherosclerosis , 2001, Current opinion in lipidology.

[31]  T. Willson,et al.  Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase , 1999, Nature.

[32]  A. Ramachandran,et al.  Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. , 2005, American journal of physiology. Heart and circulatory physiology.

[33]  R. Kolesnick,et al.  Raft ceramide in molecular medicine , 2003, Oncogene.

[34]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[35]  Masashi Komeda,et al.  Expression of SR-PSOX, a Novel Cell-Surface Scavenger Receptor for Phosphatidylserine and Oxidized LDL in Human Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[36]  S. Legrand-Poels,et al.  Perturbation of actin dynamics induces NF-kappaB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway. , 2005, The Biochemical journal.

[37]  H. Harizi,et al.  Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. , 2006, Cellular & molecular immunology.

[38]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[39]  N. Weeratunge,et al.  Toxicity of oxysterols to human monocyte-macrophages. , 1995, Atherosclerosis.

[40]  Y. Yoo,et al.  Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. , 1998, Biochemistry.

[41]  D. Steinberg,et al.  Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. , 2001, Journal of lipid research.

[42]  N. Brot,et al.  Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I* , 2006, Journal of Biological Chemistry.

[43]  T. Langmann,et al.  The Scavenger Receptor CD163: Regulation, Promoter Structure and Genomic Organization , 2000, Pathobiology.

[44]  C. Glass,et al.  Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .

[45]  M. Nakano,et al.  Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles. , 2003, Biochimica et biophysica acta.

[46]  Reto Asmis,et al.  Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxin. , 2006, Free radical biology & medicine.

[47]  A. Shah,et al.  Peroxisome Proliferator–Activated Receptor &agr; Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-&agr; Activation Properties , 2004 .

[48]  E. Gulbins,et al.  Ceramide-enriched membrane domains. , 2005, Biochimica et biophysica acta.

[49]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[50]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[51]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[52]  L. Papadopoulou,et al.  Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. , 2006, Pharmacology & therapeutics.

[53]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[54]  M. Cathcart,et al.  Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[55]  R. Kolesnick,et al.  Does endotoxin stimulate cells by mimicking ceramide? , 1995, Immunology today.

[56]  S. Bhakdi,et al.  Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions , 1990, The Journal of experimental medicine.

[57]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[58]  L. Szweda,et al.  Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. , 1998, Biochemistry.

[59]  F. DeLeo,et al.  Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.

[60]  S. Goerdt,et al.  Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9−) in psoriatic dermis , 1996, Archives of Dermatological Research.

[61]  E. Gulbins,et al.  Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells , 2006, Hypertension.

[62]  R. Kolesnick,et al.  Ceramide and sphingosine 1-phosphate in anti-cancer therapies. , 2003, Cancer treatment and research.

[63]  A. Landar,et al.  Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. , 2005, Biochemical Society transactions.

[64]  D. Shih,et al.  The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.

[65]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[66]  G. Schmitz,et al.  Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. , 2001, Atherosclerosis.

[67]  Chandan K Sen,et al.  The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. , 2007, American journal of respiratory cell and molecular biology.

[68]  G. Zimmerman,et al.  Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad (*) , 1995, The Journal of Biological Chemistry.

[69]  Jeffrey B. Kopp,et al.  TGF- and fibrosis , 1999 .

[70]  G. Schütz,et al.  Lipopolysaccharide and ceramide docking to CD14 provokes ligand‐specific receptor clustering in rafts , 2001, European journal of immunology.

[71]  M. Takeya,et al.  Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals , 2002, Medical Electron Microscopy.

[72]  Xi-Ping Huang,et al.  Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity. , 2006, Chemico-biological interactions.

[73]  G. Francis,et al.  Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[74]  V. Darley-Usmar,et al.  Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. , 1993, The Biochemical journal.

[75]  A. Sevanian,et al.  OxLDL induces macrophage gamma-GCS-HS protein expression: a role for oxLDL-associated lipid hydroperoxide in GSH synthesis. , 2001, Journal of lipid research.

[76]  M. Jaye,et al.  Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. , 2004, Free radical biology & medicine.

[77]  E. Murphy,et al.  S-nitrosylation: NO-related redox signaling to protect against oxidative stress. , 2006, Antioxidants & redox signaling.

[78]  J. Heuser,et al.  Endocytosis of Oxidized Low Density Lipoprotein through Scavenger Receptor CD36 Utilizes a Lipid Raft Pathway That Does Not Require Caveolin-1* , 2003, Journal of Biological Chemistry.

[79]  K. Hirata,et al.  Expression of Glutaredoxin in Human Coronary Arteries: Its Potential Role in Antioxidant Protection Against Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[80]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[81]  G. Poli,et al.  4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. , 2005, Molecular nutrition & food research.

[82]  K. Gaus,et al.  Oxidized lipoproteins and macrophages. , 2002, Vascular pharmacology.

[83]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[84]  W. Nacken,et al.  S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.

[85]  G. Schütz,et al.  Apo AI/ABCA1‐Dependent and HDL3‐Mediated Lipid Efflux from Compositionally Distinct Cholesterol‐Based Microdomains , 2002, Traffic.

[86]  L. Nagy,et al.  Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease. , 1999, Current opinion in lipidology.

[87]  Gaochao Zhou,et al.  27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.

[88]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[89]  M. Wilson,et al.  Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. , 1996, Journal of lipid research.

[90]  J. Huang,et al.  TGF‐β control of cell proliferation , 2005 .

[91]  S. Gordon,et al.  A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. , 1998, Journal of lipid research.

[92]  T. K. van den Berg,et al.  The macrophage scavenger receptor CD163. , 2005, Immunobiology.

[93]  D. Simon,et al.  Integrin signals, transcription factors, and monocyte differentiation. , 2006, Trends in cardiovascular medicine.

[94]  R. Dean,et al.  A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. , 1993, Analytical biochemistry.

[95]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[96]  G. Poli,et al.  Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). , 2002, The Journal of nutritional biochemistry.

[97]  P. Libby,et al.  Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.

[98]  J. Mehta,et al.  Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. , 2000, Circulation.

[99]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[100]  V. O’Donnell,et al.  Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease , 2001, Circulation research.

[101]  D. Steinberg,et al.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A. Tedgui,et al.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.

[103]  H. Masutani,et al.  Redox regulation by thioredoxin in cardiovascular diseases. , 2003, Antioxidants & redox signaling.

[104]  R. Kinscherf,et al.  Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis , 2001 .

[105]  Xavier Collet,et al.  Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis , 2003, Nature.

[106]  P. Edwards,et al.  Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Hume,et al.  Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.

[108]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[109]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[110]  T. Kodama,et al.  Collagenous macrophage scavenger receptors , 1996, Current opinion in lipidology.

[111]  S. Daniels,et al.  Serum glutathione in adolescent males predicts parental coronary heart disease. , 1999, Circulation.

[112]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[113]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[114]  L. Rajendran,et al.  Lipid rafts and membrane dynamics , 2005, Journal of Cell Science.

[115]  D. Tew,et al.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. , 1999, The Biochemical journal.

[116]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[117]  A. Nègre-Salvayre,et al.  Oxidized low-density lipoprotein-induced apoptosis. , 2002, Biochimica et biophysica acta.

[118]  S. Bhakdi,et al.  On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety , 1995, The Journal of experimental medicine.

[119]  H. Ochi,et al.  Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[120]  S. Teitelbaum,et al.  αvβ3 and macrophage colony‐stimulating factor: partners in osteoclast biology , 2005 .

[121]  M. Yacoub,et al.  Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[122]  P. Libby,et al.  Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. , 2001, The American journal of pathology.

[123]  K. Jakobs,et al.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. , 2007, Biochimica et biophysica acta.

[124]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[125]  P. Libby,et al.  Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .

[126]  R. Stocker,et al.  High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[128]  E. Leibold,et al.  Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. , 1999, Gene expression.

[129]  P. Reaven,et al.  Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[130]  Yoshimasa Nakamura,et al.  Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation , 1999, The Journal of Biological Chemistry.

[131]  T. Kondo,et al.  Diversity and complexity of ceramide signalling in apoptosis. , 1998, Cellular signalling.

[132]  S. Parthasarathy,et al.  Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[133]  Michael Aviram,et al.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants , 1998, Molecular and Cellular Biochemistry.

[134]  S. Goerdt,et al.  Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. , 1993, The American journal of pathology.

[135]  A. Nègre-Salvayre,et al.  Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway , 2004, Free radical research.

[136]  B. van Deurs,et al.  The phagocyte NADPH oxidase depends on cholesterol‐enriched membrane microdomains for assembly , 2004, The EMBO journal.

[137]  I. Yuhanna,et al.  Oxidized Low Density Lipoprotein Displaces Endothelial Nitric-oxide Synthase (eNOS) from Plasmalemmal Caveolae and Impairs eNOS Activation* , 1999, The Journal of Biological Chemistry.

[138]  P. Barter,et al.  Antiinflammatory Properties of HDL , 2004 .

[139]  E. Gulbins,et al.  Ceramide and cell death receptor clustering. , 2002, Biochimica et biophysica acta.

[140]  S. Altamentova,et al.  Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. , 1997, Biochemistry.

[141]  K. Kwiatkowska,et al.  Cell Surface Ceramide Generation Precedes and Controls FcγRII Clustering and Phosphorylation in Rafts* , 2004, Journal of Biological Chemistry.

[142]  G. Struhl,et al.  Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.

[143]  R. Stocker,et al.  Oxidation of High Density Lipoproteins , 1998, The Journal of Biological Chemistry.

[144]  Jianglin Fan,et al.  Inflammatory reactions in the pathogenesis of atherosclerosis. , 2003, Journal of atherosclerosis and thrombosis.

[145]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[146]  R. Stocker Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance , 1994, Current opinion in lipidology.

[147]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[148]  S. Rankin,et al.  Modification of low-density lipoproteins by flavonoids. , 1990, Biochemical Society transactions.

[149]  P. Mladěnka,et al.  The role of reactive oxygen and nitrogen species in cellular iron metabolism , 2006, Free radical research.

[150]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[151]  P. Svensson,et al.  Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages. , 2006, Atherosclerosis.

[152]  B. Brüne,et al.  Dualism of Oxidized Lipoproteins in Provoking and Attenuating the Oxidative Burst in Macrophages: Role of Peroxisome Proliferator-Activated Receptor-γ1 , 2002, The Journal of Immunology.

[153]  F. Byfield,et al.  OxLDL increases endothelial stiffness, force generation, and network formations⃞s⃞ The online version of this article (available at http://www.jlr.org) contains two additional figures. Published, JLR Papers in Press, January 17, 2006. , 2006, Journal of Lipid Research.

[154]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[155]  G. Francis,et al.  Administration of Tyrosyl Radical–Oxidized HDL Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[156]  V. Darley-Usmar,et al.  Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. , 1991, The Biochemical journal.

[157]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.